IRIS
GALIERO, RAFFAELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.146
AS - Asia 1.582
NA - Nord America 1.434
SA - Sud America 202
Continente sconosciuto - Info sul continente non disponibili 80
AF - Africa 18
Totale 6.462
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 2.486
US - Stati Uniti d'America 1.387
SG - Singapore 490
CN - Cina 347
IT - Italia 296
VN - Vietnam 246
HK - Hong Kong 230
BR - Brasile 171
IE - Irlanda 123
IN - India 83
KR - Corea 79
DE - Germania 76
GB - Regno Unito 32
JP - Giappone 28
FR - Francia 23
CA - Canada 17
MX - Messico 15
NL - Olanda 15
PL - Polonia 13
AT - Austria 11
BD - Bangladesh 11
ID - Indonesia 11
FI - Finlandia 10
AR - Argentina 9
LT - Lituania 8
ZA - Sudafrica 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
TR - Turchia 7
UA - Ucraina 7
CR - Costa Rica 6
PK - Pakistan 6
CO - Colombia 5
ES - Italia 5
PT - Portogallo 5
SE - Svezia 5
VE - Venezuela 5
CH - Svizzera 4
EC - Ecuador 4
IL - Israele 4
IQ - Iraq 4
MA - Marocco 4
SA - Arabia Saudita 4
BE - Belgio 3
BO - Bolivia 3
IR - Iran 3
PE - Perù 3
RO - Romania 3
AZ - Azerbaigian 2
BB - Barbados 2
EG - Egitto 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
JM - Giamaica 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MO - Macao, regione amministrativa speciale della Cina 2
MY - Malesia 2
RS - Serbia 2
SI - Slovenia 2
UZ - Uzbekistan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
HR - Croazia 1
JO - Giordania 1
LB - Libano 1
LV - Lettonia 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PY - Paraguay 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TW - Taiwan 1
UY - Uruguay 1
VG - Isole Vergini Britanniche 1
Totale 6.382
Salva come PNG Salva come JPEG
Città #
Moscow 890
San Jose 281
Singapore 245
Hong Kong 222
Santa Clara 131
Ashburn 126
Dublin 117
Council Bluffs 108
Hefei 98
Naples 83
The Dalles 82
Seoul 79
Ho Chi Minh City 72
New York 62
Hanoi 55
Bengaluru 47
Chandler 43
Los Angeles 35
Munich 35
Beijing 34
Dallas 31
Da Nang 20
São Paulo 20
Chicago 19
Milan 16
Memphis 15
Orem 13
Haiphong 12
Amsterdam 11
Frankfurt am Main 11
Kochi 11
Atlanta 10
Rome 10
Avellino 9
Salerno 9
Brooklyn 8
Falkenstein 8
Hải Dương 8
Belo Horizonte 7
Florence 7
Hillsboro 7
Liveri 7
Mexico City 7
Warsaw 7
Bexley 6
Biên Hòa 6
Boardman 6
Cambridge 6
Chennai 6
Denver 6
Princeton 6
Roxbury 6
San José 6
Tokyo 6
Vienna 6
Brno 5
Bến Tre 5
Ercolano 5
Helsinki 5
Johannesburg 5
Lahore 5
Montreal 5
Nuremberg 5
Phoenix 5
San Francisco 5
Stockholm 5
Toronto 5
Boston 4
Brasília 4
Bắc Ninh 4
Guarulhos 4
Istanbul 4
Lisbon 4
Manchester 4
Paris 4
Pelotas 4
Rio de Janeiro 4
Shanghai 4
Wroclaw 4
Yên Bái 4
Zurich 4
Boydton 3
Bremen 3
Brussels 3
Buffalo 3
Bắc Giang 3
Cagliari 3
Calgary 3
Campinas 3
Can Tho 3
Cape Town 3
La Paz 3
Lappeenranta 3
London 3
Mumbai 3
New Delhi 3
Nha Trang 3
Ninh Bình 3
Olbia 3
Porto Alegre 3
Totale 3.367
Salva come PNG Salva come JPEG
Nome #
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 205
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 194
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes 169
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 166
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 164
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 161
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 159
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 158
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 158
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 153
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 150
Comment on: Effect of Vitamin D supplementation in patients with liver cirrhosis having spontaneous bacterial peritonitis: a randomized controlled study 147
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 141
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 140
Liver Involvement in Patients With Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis 139
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 139
An Update on Betrixaban, the Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis 137
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 137
CURRENT HEPATOCELLULAR CARCINOMA SYSTEMIC PHARMACOLOGICAL TREATMENT OPTIONS 137
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 136
Advances in the Insulin-Heart Axis: Current Therapies and Future Directions 135
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 134
EFFICACY OF COVID-19 VACCINATION IN PATIENTS WITH IMMUNE SYSTEM DISORDERS AND CANCER 133
Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 133
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence 128
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 125
Diabetic Gastroparesis: Navigating Pathophysiology and Nutritional Interventions 125
Oxidative Stress in Type 2 Diabetes: Impacts from Pathogenesis to Lifestyle Modifications 125
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 124
Advances in Pharmacological Approaches for Managing Hypercholesterolemia: A Comprehensive Overview of Novel Treatments 122
Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function 120
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 120
The Significance of Statin-Associated Muscle Symptoms and Its Impact on Patient Adherence and Outcomes 120
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 118
Polypharmacy and major adverse events in atrial fibrillation 117
Optimizing Anticoagulation Management in Atrial Fibrillation: Beyond the Guidelines. How and for Whom? 116
Assessment of the Effectiveness of Ticagrelor Preloading in Mitigating Periprocedural Myocardial Injury Among Non-ST Elevation Myocardial Infarction Patients Opting for an Early Invasive Approach 113
Late Hepatocellular Carcinoma Occurrence in Patients Achieving Sustained Virological Response After Direct-Acting Antiviral Therapy: A Matter of Follow-Up or Something Else? 112
The Role of Neuropathy Screening Tools in Patients Affected by Fibromyalgia 108
NerveCheck master to screen patients with type 1 or type 2 diabetes for peripheral and cardiac autonomic neuropathy 106
Predictive Value of Fatty Liver Index for Long-Term Cardiovascular Events in Patients Receiving Liver Transplantation: The COLT Study 105
Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence 103
Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study 101
Insulin–Heart Axis: Bridging Physiology to Insulin Resistance 99
The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms 97
The Role of Lung Ultrasound in SARS-CoV-19 Pneumonia Management 93
Impact of Gliflozins on Right Heart Remodeling in Italian Patients with Type 2 Diabetes and Heart Failure: Results from the GLISCAR Real-World Study 93
Precision Medicine in Type 2 Diabetes Mellitus: Utility and Limitations 83
Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN Study 82
Remdesivir treatment and clinical outcome in non-severe hospitalized COVID-19 patients: a propensity score matching multicenter Italian hospital experience 77
Impact of empagliflozin as add-on to metformin vs metformin continuation on MASLD progression in type 2 diabetes: The IMAGIN Study 5
Totale 6.462
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.530
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202245 0 0 0 2 2 0 2 1 9 1 8 20
2022/2023221 11 12 4 10 27 11 5 8 105 10 7 11
2023/2024276 26 13 9 24 51 45 8 9 7 25 26 33
2024/2025967 4 14 3 24 154 95 123 92 164 102 88 104
2025/20264.521 247 300 240 142 394 2.283 315 198 162 98 88 54
2026/2027431 29 68 247 87 0 0 0 0 0 0 0 0
Totale 6.462